iodine I 131 monoclonal antibody F16SIP
Term · Oncology and biomedicine · MLC-T-ONC-014531
A fully human monoclonal antibody (MoAb) against human A1 domain of tenascin-C, in small immunoprotein (SIP) format conjugated with iodine 131 with potential antineoplastic activity. Iodine I 131 MoAb F16SIP binds to tenascin-C on the vascular tissues and delivers cytotoxic radiation to the tumors, thereby minimizing systemic radiotoxicity. Tenascin-C is a glycoprotein of the extracellular matrix, and the large isoform of this matrix protein is expressed and restricted around vascular structures in the tumor stroma of a variety of different tumors.
| Identifier | MLC-T-ONC-014531 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | I-131 monoclonal antibody F16SIP; (131I) monoclonal antibody F16SIP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014531",
"term": "iodine I 131 monoclonal antibody F16SIP",
"field": "Oncology and biomedicine",
"definition": "A fully human monoclonal antibody (MoAb) against human A1 domain of tenascin-C, in small immunoprotein (SIP) format conjugated with iodine 131 with potential antineoplastic activity. Iodine I 131 MoAb F16SIP binds to tenascin-C on the vascular tissues and delivers cytotoxic radiation to the tumors, thereby minimizing systemic radiotoxicity. Tenascin-C is a glycoprotein of the extracellular matrix, and the large isoform of this matrix protein is expressed and restricted around vascular structures in the tumor stroma of a variety of different tumors.",
"synonyms": [
"I-131 monoclonal antibody F16SIP",
"(131I) monoclonal antibody F16SIP"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iodine-i-131-monoclonal-antibody-f16sip/"
}
Record 9,512 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.